Skip to content
thestock.space

Neogen Chemicals (NEOGEN) had a P/E of 170.7× on 6 Nov 2026, above the industry P/E of 22.1×. Its ROCE of 6.0% is the lowest among the 7 largest Specialty Chemicals peers, and sales grew 8.7% a year over 3 years while net profit fell 17%. Debt is 1.04× equity. It is a small-cap company with a market cap of ₹7,657 Cr, ranked 29th of 204 Specialty Chemicals companies by market cap; the shares rose 64% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹2,400.00
Day high
₹2,589.70
Day low
₹2,343.20
Prev. close
₹2,408.00
Volume
2.2 L

Health check

1 good · 1 fair · 4 to check
  • ReturnsAhead

    +63.6% over a year, better than 6 of 7 peers.

  • Price tagPricier

    P/E 170.7 vs industry 22.1.

  • GrowthSteady

    Sales +8.7%, profit −16.8% a year over 3 years.

  • ProfitabilityWeak

    ROCE 6.0% vs peer median 24.4%.

  • Balance sheetStretched

    Debt 1.04× equity, interest covered 1.7×, Piotroski 3 of 9.

  • Red flags3 to check

    Return on equity is low at 3.4%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Chemicals

203 listed peers. Screen the industry

Small cap

₹7,657 Cr, #29 of 204 in its industry by size.

Moves with the market

Beta 0.82 vs the NIFTY 50: tracks the market closely.

Key metrics

Last 12 months to Sep 2026: sales ₹1,013 Cr · profit ₹40 Cr
Market cap
₹7,657 Cr
Small cap
P/E
170.7
Industry 22.1
Price to book
4.49
Peers 13.33
Dividend yield
0.04%
ROE
3.4%
Peers 23.0%
ROCE
6.0%
Peers 24.4%
Debt to equity
1.04
Debt ₹1,641 Cr
EPS (TTM)
₹14.93
Face value ₹10
OPM (TTM)
16.8%
Net margin 4.0%
Sales growth
+41.8%
Latest quarter vs a year ago
Profit growth
+144.2%
Latest quarter vs a year ago
Price to sales
7.56
EV/EBITDA 52.2

Strengths and risks

Strengths

  • Quarterly profit up 144.2% on a year ago.
  • Quarterly sales up 41.8% on a year ago.

Risks to check

  • Return on equity is low at 3.4%.
  • P/E of 170.7 against an industry P/E of 22.1.
  • Interest coverage of only 2.3×.

Derived automatically from reported figures. Not a recommendation.

About Neogen Chemicals

Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy…

Headquarters
Thane
Employees
680
Sector
Basic Materials
ISIN
INE136S01016

Price range

52 weeks

₹966.70₹2,785.00

Today

₹2,343.20₹2,589.70
Avg volume (3M)
2.2 L
1-year return
plus 63.6%
From 52-week high
minus 8.5%

Analyst consensus

11 analysts
BuyMean target ₹2,431.18 minus 4.6%

The mean target is below today’s price.

Target range, with today’s price

Low ₹2,090.00High ₹3,050.00

Consensus from Yahoo Finance. Not a recommendation.

Peers · Specialty Chemicals

Capital-heavy industry columns

Company
ASIANPAINTAsian Paints2,546.00plus 0.88%2,44,02550.535.024.4%18.9%0.211.1%plus 1.5%
SOLARINDSSolar Industries India18,608.00plus 0.48%1,68,38474.464.129.5%27.8%0.2212.4%plus 35.9%
PIDILITINDPidilite Industries1,579.00plus 1.63%1,60,82760.044.428.5%23.5%0.037.4%plus 6.8%
LINDEINDIALinde India6,859.00plus 8.73%58,496118.464.216.3%31.5%0.23–plus 5.4%
BERGEPAINTBerger Paints India478.35minus 5.28%55,77645.429.420.6%15.3%0.154.2%minus 6.0%
FLUOROCHEMGujarat Fluorochemicals4,665.50minus 0.94%51,25175.944.09.6%24.1%0.26−4.5%plus 28.0%
ACUTAASAcutaas Chemicals3,786.60plus 0.42%31,00170.964.127.7%39.4%0.0129.4%plus 105.6%
NEOGENNeogen Chemicals2,548.60plus 5.84%7,657170.765.86.0%16.7%1.048.7%plus 63.6%
Median of 7 peers–0.48%58,49670.944.424.4%24.1%0.215.8%6.8%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
209220247250296
179188203201251
3031.943.94945.3
14.4%14.5%17.8%19.6%15.3%
22.213.34
19.521.521.520.827.8
7.36.87.68.28.8
5.25.815.923.312.7
34.6%35.9%28.1%26.5%35.3%
3.43.711.417.18.2
1.281.404.326.292.96

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+8.7%
Profit CAGR 3Y
−16.8%
EPS CAGR 3Y
−18.4%
ROE
3.4%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
660671756848
–+1.6%+12.7%+12.2%
549561619711
112110137137
16.9%16.4%18.1%16.2%
−0.73.4−6.4−7.7
23.737.837.961
16.222.927.827.5
––−15−0.2
7152.850.241.1
29.6%32.4%30.6%30.0%
5035.734.828.8
–minus 28.7%minus 2.3%minus 17.5%
20.0313.9613.2010.90

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
24.926.426.426.4
458734763790
3704095971,395
202292361691
1,0541,4611,7472,902
3866627261,469
39.6168323995
8.20.51.934.3
96.815.354.9
524616692398
1,0541,4611,7472,902

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−30.4−29.2196−231
−94.5−216−317−410
100237113642
−24.5−8.2−7.5−0
−104−303−318−556
−134−332−122−787
−6.9−7.5−5.3−2.6

Shareholding pattern

Source: NSE filings

NSE hasn’t returned a shareholding pattern for this company. Institutions hold about 20.2% (Yahoo estimate).

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you